Literature DB >> 28603736

Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges.

Hong Tian1,2, Wei Li2,3.   

Abstract

Entities:  

Year:  2017        PMID： 28603736      PMCID： PMC5451628          DOI： 10.21037/atm.2017.02.23

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

1.  Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ.

Authors:  Sophie Viaud; Stéphanie Ploix; Valérie Lapierre; Clotilde Théry; Pierre-Henri Commere; Dominique Tramalloni; Kevin Gorrichon; Pauline Virault-Rocroy; Thomas Tursz; Olivier Lantz; Laurence Zitvogel; Nathalie Chaput
Journal:  J Immunother       Date:  2011-01       Impact factor: 4.456

Review 2.  The future of immune checkpoint therapy.

Authors:  Padmanee Sharma; James P Allison
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

3.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

Review 4.  DCVax®-L--developed by Northwest Biotherapeutics.

Authors:  Stavros Polyzoidis; Keyoumars Ashkan
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).

Authors:  R M Johnstone; M Adam; J R Hammond; L Orr; C Turbide
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

Review 6.  Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

Authors:  Kalijn F Bol; Gerty Schreibelt; Winald R Gerritsen; I Jolanda M de Vries; Carl G Figdor
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

7.  Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.

Authors:  Kalijn F Bol; Hanneke W Mensink; Erik H J G Aarntzen; Gerty Schreibelt; Jan E E Keunen; Pierre G Coulie; Annelies de Klein; Cornelis J A Punt; Dion Paridaens; Carl G Figdor; I Jolanda M de Vries
Journal:  Am J Ophthalmol       Date:  2014-07-17       Impact factor: 5.258

8.  Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.

Authors:  Bettina Schreiner; Meike Mitsdoerffer; Bernd C Kieseier; Lieping Chen; Hans-Peter Hartung; Michael Weller; Heinz Wiendl
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

9.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.

Authors:  Michael A Morse; Jennifer Garst; Takuya Osada; Shubi Khan; Amy Hobeika; Timothy M Clay; Nancy Valente; Revati Shreeniwas; Mary Ann Sutton; Alain Delcayre; Di-Hwei Hsu; Jean-Bernard Le Pecq; H Kim Lyerly
Journal:  J Transl Med       Date:  2005-02-21       Impact factor: 5.531

Review 10.  Prospects for exosomes in immunotherapy of cancer.

Authors:  G Mignot; S Roux; Clotilde Thery; Elodie Ségura; L Zitvogel
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310
View more
  25 in total

1.  Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.

Authors:  Chunmei Fu; Peng Peng; Jakob Loschko; Li Feng; Phuong Pham; Weiguo Cui; Kelvin P Lee; Anne B Krug; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

2.  Microfluidic on-demand engineering of exosomes towards cancer immunotherapy.

Authors:  Zheng Zhao; Jodi McGill; Pamela Gamero-Kubota; Mei He
Journal:  Lab Chip       Date:  2019-05-14       Impact factor: 6.799

Review 3.  Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.

Authors:  Qingfu Zhu; Mikala Heon; Zheng Zhao; Mei He
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

Review 4.  Small extracellular vesicles in cancer.

Authors:  Komal Abhange; Amy Makler; Yi Wen; Natasha Ramnauth; Wenjun Mao; Waseem Asghar; Yuan Wan
Journal:  Bioact Mater       Date:  2021-04-07

Review 5.  Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer.

Authors:  Fernanda G Kugeratski; Kathleen M McAndrews; Raghu Kalluri
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 5.051

Review 6.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment.

Authors:  Joana Maia; Sergio Caja; Maria Carolina Strano Moraes; Nuno Couto; Bruno Costa-Silva
Journal:  Front Cell Dev Biol       Date:  2018-02-20

Review 7.  Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications.

Authors:  Marco Ragusa; Cristina Barbagallo; Matilde Cirnigliaro; Rosalia Battaglia; Duilia Brex; Angela Caponnetto; Davide Barbagallo; Cinzia Di Pietro; Michele Purrello
Journal:  Front Mol Biosci       Date:  2017-10-04

Review 8.  Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.

Authors:  Carla Giacobino; Marta Canta; Cristina Fornaguera; Salvador Borrós; Valentina Cauda
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 9.  Exosomes as mediators of immune regulation and immunotherapy in cancer.

Authors:  Fernanda G Kugeratski; Raghu Kalluri
Journal:  FEBS J       Date:  2020-10-03       Impact factor: 5.622

Review 10.  The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses.

Authors:  Liangshun You; Liping Mao; Juying Wei; Shenhe Jin; Chunmei Yang; Hui Liu; Li Zhu; Wenbin Qian
Journal:  J Hematol Oncol       Date:  2017-10-23       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.